Loading…
Nucleai provides an AI-driven spatial biomarker platform that analyzes complex cellular interactions in patient biopsies to accelerate drug development and diagnostics. Its technology integrates multimodal imaging data to deliver actionable insights for biomarker discovery, therapy response prediction, and precision medicine.
AI named Nucleai in November 2025.